文献速递皮肤肿瘤

活化Hgf-Met信号与致癌BRAF协同驱动小鼠原发性皮肤黑色素瘤及嗜血管性肺转移

Activated Hgf-Met Signaling Cooperates with Oncogenic BRAF to Drive Primary Cutaneous Melanomas and Angiotropic Lung Metastases in Mice.
PubMed 文献 · J Invest Dermatol · 2020-01-20

该研究利用转基因小鼠模型,探讨组成性增强的Hgf-Met信号与致癌BRAF突变在黑色素瘤发病中的协同作用。结果显示,在Hgf过表达且携带致癌CDK4胚系突变的小鼠中激活致癌BRAF,可加速并增加原发性皮肤黑色素瘤的发生,肿瘤呈现去分化表型异质性,并增加肺转移数量。黑色素瘤细胞在原发性肿瘤侵袭前沿和肺转移灶中均表现出显著的嗜血管性生长模式。

要点

  • Hgf-Met信号增强与致癌BRAF协同加速原发性皮肤黑色素瘤发生。
  • 该协同作用增加肺转移数量,并呈现嗜血管性生长模式。
  • 原发性黑色素瘤表现出明显的表型异质性及去分化征象。

核心结论

  • 活化的Hgf-Met信号与致癌BRAF可在黑色素瘤发病机制中协同作用。

研究设计与样本

  • 研究采用遗传小鼠模型,在Hgf过表达且携带致癌CDK4胚系突变的小鼠中激活致癌BRAF。

主要发现

  • 在Hgf过表达和致癌CDK4胚系突变的小鼠中激活致癌BRAF,加速并增加了原发性皮肤黑色素瘤的发生。
  • 原发性黑色素瘤表现出显著的表型异质性,并常见去分化征象。
  • 在Hgf-CDK4小鼠中激活BRAF增加了肺转移的数量。
  • 黑色素瘤细胞在原发性肿瘤侵袭前沿和肺转移灶中均呈现显著的嗜血管性生长模式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Oncogenic mutations in the BRAF kinase gene represent the most frequent genomic driver in acquired melanocytic nevi and in cutaneous melanomas. It is currently thought that oncogene-induced senescence and cell cycle arrest limit the ability of oncogenic BRAF to promote melanocyte proliferation in benign nevi. The molecular and cellular mechanisms that allow an oncogenic BRAF mutation to fully transform melanocytes into invasively growing melanoma cells that are able to metastasize systemically are only partially understood. In this study, we show in a genetic mouse model that constitutively enhanced Hgf-Met signaling cooperates with oncogenic BRAF to drive tumor development and metastatic spread. Activation of oncogenic BRAF in mice with transgenic Hgf overexpression and an oncogenic CDK4 germline mutation accelerated and increased the development of primary cutaneous melanomas. Primary melanomas showed considerable phenotypic heterogeneity with frequent signs of dedifferentiation. BRAF activation in Hgf-CDK4 mice also increased the number of lung metastases. Melanoma cells showed a pronounced angiotropic growth pattern both at the invasive front in primary tumors and in metastatic lesions of the lung. Taken together, our work supports the notion that activated Hgf-Met signaling and oncogenic BRAF can cooperate in melanoma pathogenesis.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Braun AD, Mengoni M, Bonifatius S, et al. Activated Hgf-Met Signaling Cooperates with Oncogenic BRAF to Drive Primary Cutaneous Melanomas and Angiotropic Lung Metastases in Mice. J Invest Dermatol. 2020. PMID: 31972251. doi:10.1016/j.jid.2019.12.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。